Manjishthadi Agad in Pandu.

Randomised contolled clinical trials to evaluate the efficacy of Manjishthadi Agad in management of Garavishajanya Pandu. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082052

Enrollment

194

Registered

2025-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T629- Toxic effect of unspecified noxious substance eaten as food

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients selected by irrespective of Cast Economic status religion Who gives informed written concent

Exclusion criteria

Exclusion criteria: Patients who dont give informed written consent lactating mother And Pregnant Woman Bleeding disorders Patients participating in any other clinical trials Hb percentage below 7% severe systemic diseases like Ascites CCF ARF CRF AIDS TB Leprocy Any Malignancy Gastric ulcer Autoimmune diseases Patients who is on other medications surgical disorders like Appendix hernia

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Manjishthadi Agad in management of Garavishajanya Pandu.Timepoint: On 0th day, 15th day, 30th day, 45th day, 60th day.	—

Secondary

Measure	Time frame
Standardization and Analytical study of Manjishthadi Agad. To study the Panduroga in detail.Timepoint: On 0th day, 15th day, 30th day, 45th day, 60th day.	—

Countries

India

Contacts

Public ContactDR N S Gangasagre

Government Ayurvedic College Tulajapur Naka Dharashiv

gacosbd@gmail.com09422165970

Outcome results